A validated score to predict one-year and long-term mortality in patients with significant tricuspid regurgitation.

Aviram Hochstadt Elad Maor Eihab GhantousIlan MerdlerYoav GranotRonen RubinshteinShmuel BanaiAmit SegevRafael KupersteinYan Topilsky

Published in: European heart journal open (2022)

We suggest a robust risk score for inpatients with significant TR, assisting risk stratification and decision-making. Our findings underscore the burden of TR providing benchmarks for clinical trial design.

Keyphrases

clinical trial
decision making
aortic valve
aortic stenosis
risk factors
transcatheter aortic valve replacement
mitral valve
cardiovascular events
open label
phase ii
double blind
ejection fraction
heart failure
type diabetes
left ventricular